Header
Sir Ganga Ram Hospital, New Delhi
Pancreatic Cancer Stages, Survival Rates and Treatment.
Medically Reviewed by Dr. Aditya Sarin, MD, DrNB
Cancer Care · Sir Ganga Ram Hospital, New Delhi

Pancreatic Cancer —
Expertise at Every Stage.

A comprehensive guide to pancreatic cancer — from understanding the disease to diagnosis, staging, and treatment — by Dr. Aditya Sarin, ESMO Board Certified Medical Oncologist.

Medical Disclaimer

This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of pancreatic cancer is different. Please consult Dr. Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

Early detection significantly improves survival rates. If you or a loved one has symptoms or risk factors for pancreatic cancer, consult Dr. Aditya Sarin without delay.

Section 01

What is Pancreatic Cancer?

Pancreatic cancer is a serious disease that starts in the pancreas — an organ located behind the stomach that plays a vital role in digestion and blood sugar regulation. The pancreas produces enzymes to aid digestion and hormones like insulin to control blood sugar levels. When cancerous cells form in the pancreas, they can grow aggressively and spread to other parts of the body.

Section 02

Types of Pancreatic Cancer

Exocrine Tumors

90% of cases
  • Adenocarcinoma — The most common type, starting in the pancreatic ducts.
  • Acinar Cell Carcinoma — A rare type affecting enzyme-producing cells.

Endocrine Tumors (PNETs)

Less Common
  • Arise from hormone-producing cells — may be benign or malignant.
  • Insulinomas, Glucagonomas, Gastrinomas.
Section 03

Symptoms of Pancreatic Cancer

Pancreatic cancer often shows no symptoms in the early stages, making early detection difficult. As the disease progresses, the following symptoms may appear:

Persistent abdominal or back pain
Jaundice — yellowing of skin and eyes
Unexplained weight loss and loss of appetite
Dark urine and pale stools
Nausea, vomiting, and digestive problems
New-onset or worsening diabetes
Fatigue and weakness
Section 04

Causes & Risk Factors

While the exact cause of pancreatic cancer is unknown, several factors significantly increase the risk:

Smoking

A major modifiable risk factor for pancreatic cancer.

Age

More common in people over 60 years of age.

Family History & Genetics

BRCA mutations and hereditary syndromes increase risk.

Chronic Pancreatitis

Long-term inflammation of the pancreas raises risk.

Obesity & Poor Diet

High-fat diets and obesity are linked to higher risk.

Diabetes

Long-standing or newly developed diabetes can be a risk factor.

Excessive Alcohol

Can lead to chronic pancreatitis, increasing cancer risk.

Section 05

Diagnosis of Pancreatic Cancer

Since early-stage pancreatic cancer is difficult to detect, doctors use a combination of tests:

Imaging Tests
  • CT Scan / MRI — detailed pancreas imaging
  • Endoscopic Ultrasound (EUS) — tumor visualization
  • PET Scan — detects cancer spread
Blood Tests
  • CA 19-9 tumor marker — indicates cancer presence
  • Liver function tests
  • Complete blood count (CBC)
Biopsy
  • Tissue sample analyzed for cancer cells
  • EUS-guided fine needle aspiration
  • Surgical biopsy when indicated
Section 06

Stages of Pancreatic Cancer

I

Localized

Cancer is confined to the pancreas. Best prognosis — surgery may be curative.

II

Regional

May have spread to nearby lymph nodes. Surgery with adjuvant therapy indicated.

III

Advanced

Spread to major blood vessels or lymph nodes. Often requires combined therapy.

IV

Metastatic

Spread to distant organs — liver or lungs. Systemic therapy and palliative care.

Section 07

Survival Rates by Stage

Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient. Pancreatic cancer has some of the lowest survival rates among common cancers, largely because it produces few symptoms in its early stages.

Pancreatic cancer survival rate in the United States

Stage at diagnosis
5-year rate
Localized — confined to the pancreas
44%
Regional — spread to nearby structures or lymph nodes
17%
Distant — spread to other organs
3%
All stages combined
13%

Source: American Cancer Society, Survival Rates for Pancreatic Cancer, based on SEER data for cases diagnosed between 2015 and 2021.

Pancreatic cancer survival rate in Asia

Nationally representative, stage-wise survival data specific to pancreatic cancer is limited in India. The closest available regional context comes from a systematic review of Asian countries, which found a 5-year survival rate of 9.7 percent — lower than the equivalent United States figure above.

Source: Survival rate of pancreatic cancer in Asian countries, a systematic review and meta-analysis, 2025.

Section 08

Treatment Options for Pancreatic Cancer

Treatment depends on the stage, location of the cancer, and the patient's overall health. A multidisciplinary approach delivers the best outcomes.

Surgery

The most effective curative option for early-stage disease.

  • Whipple Procedure (Pancreaticoduodenectomy)
  • Distal Pancreatectomy
  • Total Pancreatectomy (rarely done)

Radiation Therapy

High-energy beams to kill cancer cells and shrink tumors. Often combined with chemotherapy or surgery.

Chemotherapy

Drugs to kill cancer cells or stop their growth. Often combined with surgery or radiation for maximum effect.

Targeted Therapy

Attacks specific genes or proteins in cancer cells to stop their growth with greater precision and fewer side effects.

Immunotherapy

Helps the body's immune system recognize and destroy cancer cells — particularly effective in select molecular subtypes.

Palliative Care

Focuses on improving quality of life by managing symptoms like pain, jaundice, and digestion problems in advanced disease.

Section 09

Latest Advances in Pancreatic Cancer Treatment

Pancreatic cancer research has produced some of its most promising results in years, particularly for unresectable and biomarker-specific disease. As of 2026, notable developments include the following.

1
Phase 3 PANOVA-3 Trial · 2025

First survival benefit from tumour treating fields

The Phase 3 PANOVA-3 trial found an 18 percent improvement in overall survival when tumour treating fields — a wearable device delivering electrical fields to disrupt cancer cell division — were added to standard chemotherapy for unresectable, locally advanced pancreatic cancer.

This was the first Phase 3 trial in this setting to show an overall survival benefit beyond chemotherapy alone.

Source: Let's Win Pancreatic Cancer — Rewinding 2025, A Year in Pancreatic Cancer Research.

2
FDA Accelerated Approval · Rare NRG1 Fusion

New targeted option for a rare genetic subtype

Zenocutuzumab received FDA accelerated approval for advanced pancreatic ductal adenocarcinoma with an NRG1 gene fusion — a rare mutation found in under 1 percent of cases — with a 40 percent objective response rate in the supporting trial.

Source: Discover Oncology — Emerging therapeutic advancements in pancreatic cancer, a contemporary review, 2025.

3
FDA Approval · March 2025 · PNETs

New option for neuroendocrine tumours

In March 2025, the FDA approved cabozantinib for previously treated advanced pancreatic neuroendocrine tumours — the subtype covered in Section 02 — representing a new standard of care for this specific group of patients.

Source: Pancreatic Cancer Action Network — Research Spotlight, Pancreatic Cancer in 2025.

Whether any of these apply to a given patient depends on tumour subtype, biomarker testing, and whether the disease is resectable, and should be discussed directly with an oncologist.
Section 10

Life After Pancreatic Cancer Treatment

Regular Follow-Ups

Monitoring for recurrence with imaging and blood marker tests.

Nutritional Support

Dietary adjustments and enzyme supplements to aid digestion and maintain weight.

Managing Diabetes

Many patients develop diabetes after pancreatic surgery — closely monitored and managed.

Emotional Support

Counseling and support groups to help cope with the disease and recovery journey.

Section 11

Frequently Asked Questions about Pancreatic Cancer

Why is pancreatic cancer often caught so late?

Pancreatic cancer typically produces no clear symptoms in its early stages, and when symptoms like abdominal pain or jaundice do appear, they are often mistaken for less serious digestive issues. This is why over half of cases are diagnosed only after the cancer has already spread to distant organs.

Is pancreatic cancer hereditary?

Most cases are not directly inherited, but a meaningful proportion are linked to inherited factors, including BRCA1 and BRCA2 mutations and certain hereditary syndromes. A strong family history of pancreatic, breast, or ovarian cancer is a reason to discuss genetic counselling with an oncologist.

What is the difference between exocrine and endocrine pancreatic tumours?

Exocrine tumours, which make up about 90 percent of cases, arise from the pancreas's digestive enzyme-producing cells and include adenocarcinoma, the most common type. Endocrine tumours, or PNETs, arise from hormone-producing cells, are less common, and generally have a different treatment approach and outlook.

Can pancreatic cancer be found early through screening?

There is no routine population-wide screening test for pancreatic cancer. Screening with imaging is generally reserved for people at significantly elevated risk, such as those with a strong family history or known genetic mutations, rather than the general population.

Is surgery always an option for pancreatic cancer?

No. Surgery, such as the Whipple procedure, offers the best chance of cure but is only possible when the cancer is still localized and has not involved major blood vessels. For many patients diagnosed at a later stage, treatment instead focuses on chemotherapy, targeted therapy, and symptom management.

Does a pancreatic cancer diagnosis always mean diabetes?

Not necessarily, but there is a strong connection. New-onset or worsening diabetes can sometimes be an early warning sign of pancreatic cancer, and many patients also develop diabetes after pancreatic surgery, which requires ongoing monitoring and management.

What is the best treatment approach for Pancreatic Cancer in Delhi?

Effective pancreatic cancer treatment in Delhi requires prompt, accurate staging and a multidisciplinary evaluation of whether surgery is possible, since this is the single biggest factor in outcome for this cancer. Dr. Aditya Sarin coordinates this kind of multidisciplinary pancreatic cancer care, including biomarker and genetic testing where relevant, at Sir Ganga Ram Hospital, New Delhi.
Section 12 · Why Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Pancreatic Cancer Care?

Early detection improves survival rates — book an appointment at Sir Ganga Ram Hospital today.

Expert Oncologists

A team of experienced specialists in pancreatic cancer with ESMO-level training and deep clinical expertise.

Advanced Diagnostics

State-of-the-art imaging, EUS, CA 19-9 testing, and cutting-edge genetic profiling for precise diagnosis.

Comprehensive Treatment

Surgery, chemotherapy, targeted therapy, and supportive care — all integrated under one roof.

Personalized Care Plans

Tailored treatment strategies based on each patient's cancer stage, genetics, and overall health profile.

Supportive Care & Rehab

Guidance on nutrition, diabetes management, physiotherapy, and mental well-being post-treatment.

Mon – Fri (Morning) 10:00 AM – 12:00 PM
Mon – Fri (Evening) 4:00 PM – 6:00 PM
Saturday - Sunday Closed

Don't Wait — Early Detection Saves Lives

If you or a loved one has symptoms or risk factors for pancreatic cancer, book a consultation with Dr. Aditya Sarin today.

📅 Book Your Appointment
Pancreatic Cancer Stages, Survival Rates and Treatment.
Cancer Care · Sir Ganga Ram Hospital, New Delhi

Pancreatic Cancer —
Expertise at Every Stage.

A comprehensive guide to pancreatic cancer — from understanding the disease to diagnosis, staging, and treatment — by Dr. Aditya Sarin, ESMO Board Certified Medical Oncologist.

Medical Disclaimer

This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of pancreatic cancer is different. Please consult Dr. Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

Early detection significantly improves survival rates. If you or a loved one has symptoms or risk factors for pancreatic cancer, consult Dr. Aditya Sarin without delay.

Section 01

What is Pancreatic Cancer?

Pancreatic cancer is a serious disease that starts in the pancreas — an organ located behind the stomach that plays a vital role in digestion and blood sugar regulation. The pancreas produces enzymes to aid digestion and hormones like insulin to control blood sugar levels. When cancerous cells form in the pancreas, they can grow aggressively and spread to other parts of the body.

Section 02

Types of Pancreatic Cancer

Exocrine Tumors

90% of cases
  • Adenocarcinoma — The most common type, starting in the pancreatic ducts.
  • Acinar Cell Carcinoma — A rare type affecting enzyme-producing cells.

Endocrine Tumors (PNETs)

Less Common
  • Arise from hormone-producing cells — may be benign or malignant.
  • Insulinomas, Glucagonomas, Gastrinomas.
Section 03

Symptoms of Pancreatic Cancer

Pancreatic cancer often shows no symptoms in the early stages, making early detection difficult. As the disease progresses, the following symptoms may appear:

Persistent abdominal or back pain
Jaundice — yellowing of skin and eyes
Unexplained weight loss and loss of appetite
Dark urine and pale stools
Nausea, vomiting, and digestive problems
New-onset or worsening diabetes
Fatigue and weakness
Section 04

Causes & Risk Factors

While the exact cause of pancreatic cancer is unknown, several factors significantly increase the risk:

Smoking

A major modifiable risk factor for pancreatic cancer.

Age

More common in people over 60 years of age.

Family History & Genetics

BRCA mutations and hereditary syndromes increase risk.

Chronic Pancreatitis

Long-term inflammation of the pancreas raises risk.

Obesity & Poor Diet

High-fat diets and obesity are linked to higher risk.

Diabetes

Long-standing or newly developed diabetes can be a risk factor.

Excessive Alcohol

Can lead to chronic pancreatitis, increasing cancer risk.

Section 05

Diagnosis of Pancreatic Cancer

Since early-stage pancreatic cancer is difficult to detect, doctors use a combination of tests:

Imaging Tests
  • CT Scan / MRI — detailed pancreas imaging
  • Endoscopic Ultrasound (EUS) — tumor visualization
  • PET Scan — detects cancer spread
Blood Tests
  • CA 19-9 tumor marker — indicates cancer presence
  • Liver function tests
  • Complete blood count (CBC)
Biopsy
  • Tissue sample analyzed for cancer cells
  • EUS-guided fine needle aspiration
  • Surgical biopsy when indicated
Section 06

Stages of Pancreatic Cancer

I

Localized

Cancer is confined to the pancreas. Best prognosis — surgery may be curative.

II

Regional

May have spread to nearby lymph nodes. Surgery with adjuvant therapy indicated.

III

Advanced

Spread to major blood vessels or lymph nodes. Often requires combined therapy.

IV

Metastatic

Spread to distant organs — liver or lungs. Systemic therapy and palliative care.

Section 07

Survival Rates by Stage

Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient. Pancreatic cancer has some of the lowest survival rates among common cancers, largely because it produces few symptoms in its early stages.

Pancreatic cancer survival rate in the United States

Stage at diagnosis
5-year rate
Localized — confined to the pancreas
44%
Regional — spread to nearby structures or lymph nodes
17%
Distant — spread to other organs
3%
All stages combined
13%

Source: American Cancer Society, Survival Rates for Pancreatic Cancer, based on SEER data for cases diagnosed between 2015 and 2021.

Pancreatic cancer survival rate in Asia

Nationally representative, stage-wise survival data specific to pancreatic cancer is limited in India. The closest available regional context comes from a systematic review of Asian countries, which found a 5-year survival rate of 9.7 percent — lower than the equivalent United States figure above.

Source: Survival rate of pancreatic cancer in Asian countries, a systematic review and meta-analysis, 2025.

Section 08

Treatment Options for Pancreatic Cancer

Treatment depends on the stage, location of the cancer, and the patient's overall health. A multidisciplinary approach delivers the best outcomes.

Surgery

The most effective curative option for early-stage disease.

  • Whipple Procedure (Pancreaticoduodenectomy)
  • Distal Pancreatectomy
  • Total Pancreatectomy (rarely done)

Radiation Therapy

High-energy beams to kill cancer cells and shrink tumors. Often combined with chemotherapy or surgery.

Chemotherapy

Drugs to kill cancer cells or stop their growth. Often combined with surgery or radiation for maximum effect.

Targeted Therapy

Attacks specific genes or proteins in cancer cells to stop their growth with greater precision and fewer side effects.

Immunotherapy

Helps the body's immune system recognize and destroy cancer cells — particularly effective in select molecular subtypes.

Palliative Care

Focuses on improving quality of life by managing symptoms like pain, jaundice, and digestion problems in advanced disease.

Section 09

Latest Advances in Pancreatic Cancer Treatment

Pancreatic cancer research has produced some of its most promising results in years, particularly for unresectable and biomarker-specific disease. As of 2026, notable developments include the following.

1
Phase 3 PANOVA-3 Trial · 2025

First survival benefit from tumour treating fields

The Phase 3 PANOVA-3 trial found an 18 percent improvement in overall survival when tumour treating fields — a wearable device delivering electrical fields to disrupt cancer cell division — were added to standard chemotherapy for unresectable, locally advanced pancreatic cancer.

This was the first Phase 3 trial in this setting to show an overall survival benefit beyond chemotherapy alone.

Source: Let's Win Pancreatic Cancer — Rewinding 2025, A Year in Pancreatic Cancer Research.

2
FDA Accelerated Approval · Rare NRG1 Fusion

New targeted option for a rare genetic subtype

Zenocutuzumab received FDA accelerated approval for advanced pancreatic ductal adenocarcinoma with an NRG1 gene fusion — a rare mutation found in under 1 percent of cases — with a 40 percent objective response rate in the supporting trial.

Source: Discover Oncology — Emerging therapeutic advancements in pancreatic cancer, a contemporary review, 2025.

3
FDA Approval · March 2025 · PNETs

New option for neuroendocrine tumours

In March 2025, the FDA approved cabozantinib for previously treated advanced pancreatic neuroendocrine tumours — the subtype covered in Section 02 — representing a new standard of care for this specific group of patients.

Source: Pancreatic Cancer Action Network — Research Spotlight, Pancreatic Cancer in 2025.

Whether any of these apply to a given patient depends on tumour subtype, biomarker testing, and whether the disease is resectable, and should be discussed directly with an oncologist.
Section 10

Life After Pancreatic Cancer Treatment

Regular Follow-Ups

Monitoring for recurrence with imaging and blood marker tests.

Nutritional Support

Dietary adjustments and enzyme supplements to aid digestion and maintain weight.

Managing Diabetes

Many patients develop diabetes after pancreatic surgery — closely monitored and managed.

Emotional Support

Counseling and support groups to help cope with the disease and recovery journey.

Section 11

Frequently Asked Questions about Pancreatic Cancer

Why is pancreatic cancer often caught so late?
Pancreatic cancer typically produces no clear symptoms in its early stages, and when symptoms like abdominal pain or jaundice do appear, they are often mistaken for less serious digestive issues. This is why over half of cases are diagnosed only after the cancer has already spread to distant organs.
Is pancreatic cancer hereditary?
Most cases are not directly inherited, but a meaningful proportion are linked to inherited factors, including BRCA1 and BRCA2 mutations and certain hereditary syndromes. A strong family history of pancreatic, breast, or ovarian cancer is a reason to discuss genetic counselling with an oncologist.
What is the difference between exocrine and endocrine pancreatic tumours?
Exocrine tumours, which make up about 90 percent of cases, arise from the pancreas's digestive enzyme-producing cells and include adenocarcinoma, the most common type. Endocrine tumours, or PNETs, arise from hormone-producing cells, are less common, and generally have a different treatment approach and outlook.
Can pancreatic cancer be found early through screening?
There is no routine population-wide screening test for pancreatic cancer. Screening with imaging is generally reserved for people at significantly elevated risk, such as those with a strong family history or known genetic mutations, rather than the general population.
Is surgery always an option for pancreatic cancer?
No. Surgery, such as the Whipple procedure, offers the best chance of cure but is only possible when the cancer is still localized and has not involved major blood vessels. For many patients diagnosed at a later stage, treatment instead focuses on chemotherapy, targeted therapy, and symptom management.
Does a pancreatic cancer diagnosis always mean diabetes?
Not necessarily, but there is a strong connection. New-onset or worsening diabetes can sometimes be an early warning sign of pancreatic cancer, and many patients also develop diabetes after pancreatic surgery, which requires ongoing monitoring and management.
What is the best treatment approach for Pancreatic Cancer in Delhi?
Effective pancreatic cancer treatment in Delhi requires prompt, accurate staging and a multidisciplinary evaluation of whether surgery is possible, since this is the single biggest factor in outcome for this cancer. Dr. Aditya Sarin coordinates this kind of multidisciplinary pancreatic cancer care, including biomarker and genetic testing where relevant, at Sir Ganga Ram Hospital, New Delhi.
Section 12 · Why Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Pancreatic Cancer Care?

Early detection improves survival rates — book an appointment at Sir Ganga Ram Hospital today.

Expert Oncologists

A team of experienced specialists in pancreatic cancer with ESMO-level training and deep clinical expertise.

Advanced Diagnostics

State-of-the-art imaging, EUS, CA 19-9 testing, and cutting-edge genetic profiling for precise diagnosis.

Comprehensive Treatment

Surgery, chemotherapy, targeted therapy, and supportive care — all integrated under one roof.

Personalized Care Plans

Tailored treatment strategies based on each patient's cancer stage, genetics, and overall health profile.

Supportive Care & Rehab

Guidance on nutrition, diabetes management, physiotherapy, and mental well-being post-treatment.

Mon – Fri (Morning) 10:00 AM – 12:00 PM
Mon – Fri (Evening) 4:00 PM – 6:00 PM
Saturday - Sunday Closed

Don't Wait — Early Detection Saves Lives

If you or a loved one has symptoms or risk factors for pancreatic cancer, book a consultation with Dr. Aditya Sarin today.

📅 Book Your Appointment

Pancreatic Cancer